Background The natural history of low-grade dysplasia (LGD) in patients with Barrett's
esophagus (BE) is unclear. Objective We performed a systematic review and meta-analysis …

OBJECTIVES: Endoscopic eradication therapy is used to treat mucosal neoplasms in
Barrett's esophagus, but cannot cure cancers that have metastasized to lymph nodes. The …

Introduction The risk of oesophageal adenocarcinoma (OAC) in non-dysplastic Barrett9s
oesophagus (BO) may have been overestimated. The objective was to estimate the …

Background: Surveying vs. performing resection in patients with high-grade dysplasia in
Barrett's esophagus is debated because of concern about the accuracy of endoscopic …

From the epidemiologic and therapeutic point of view, tumours of the gastroesophageal
junction should be classified either as adenocarcinoma of the distal esophagus (Type I), true …

Background—The efficacy of endoscopic biopsy surveillance of Barrett's oesophagus in
reducing mortality from oesophageal cancer has not been confirmed. Aims—To investigate …

The factors contributing to the development of esophageal mucosal injury in
gastroesophageal reflux disease (GERD) are unclear. The lower esophageal sphincter …

Objective To outline current concepts regarding etiology, diagnosis, and treatment of
intestinal metaplasia of the esophagus and cardia. Summary Background Data Previously …

Background: The optimal management of high-grade dysplasia in patients with Barrett's
esophagus is controversial. The aim of this study was to assess the prevalence of …

Background & Aims: The first therapeutic experiences with the conventional photosensitizer
dihematoporphyrinester in the treatment of Barrett's esophagus show the curative potential …